Skip to content
MarketScale
‹ Back to IndustriesHealthcare

HIMSS 2023: Providers and Payers Maneuver “Too Much Data,” SDOH Initiatives, and “Hospital in the Home”

HIMSS 2023 was the host of several industry-defining conversations for the healthcare industry, including reflections on the growth of data use in healthcare and the evolution of how and where care is administered. The evolution of the healthcare marketplace has resulted in the saturation of data among multiple areas. As a result, the healthcare…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

HIMSS 2023 was the host of several industry-defining conversations for the healthcare industry, including reflections on the growth of data use in healthcare and the evolution of how and where care is administered.

The evolution of the healthcare marketplace has resulted in the saturation of data among multiple areas. As a result, the healthcare industry must be innovative in devising ways to channel this data in a meaningful way to serve their customers efficiently. From operations to validity and privacy, measures need to be taken to find a safe place for this data to reside.

Health equity and new initiatives buzzing around the retail community are sparking the possibility of ‘hospital in the home.’ The development of such programs will not only open more space in local hospitals but create a more comfortable environment for patients to recover in their own homes, giving healthcare organizations opportunities to channel data through remote devices.

Jonathan Wiik, Vice President of Healthcare Analytics at FinThrive, shares his takeaways from HIMSS 2023, and how these data and health equity goals are shaping out for payers and providers. has a great opportunity to capitalize on the dispersion of these different data sets, serving as a broker for these data transactions.

Jonathan’s Thoughts

“Spent the last four days here at HIMSS 2023. A lot of different themes I heard when I was here. Data, I would argue that the market is starting to realize it probably has too much data, trying to figure out exactly where it needs to go, right person, right time, right place to derive better outcomes with care and payment.

Sat in on several sessions today just understanding interoperability rules, data integrity rules, data validation rules, privacy rules, operationalizing where all that data needs to live and why.

From the payment side, saw lots and lots of discussions surrounding payer and provider transactions and what that looks like from a accountability standpoint. From the provider side of the payers, really want some transparency going back to the provider community surrounding payment rules and following that so they could do their jobs at managing care. Heard SDOH a lot. That was a buzzword two or three years ago. It’s back, baby. Social determinants of health is I think front and center as you’re looking at DEI and health equity initiatives.

I interviewed Alex Wendling from Utica University this morning, and he talked about how he has taken some data sets in state of New York and looked at how some of these social determinants datas can really drive health equity through Robert Wood Johnson Foundation, and what matters and why it’s important to understand those data sets and driving care.

Also talked with a gentleman, Geoffrey Roche, about some work that he’s done with AARP and in the state of Pennsylvania surrounding health equity and really being culturally competent at your organization to where you’re meeting the needs of others.

I’ve sat in on several sessions: Walmart, Best Buy, and all of those folks are here from the retail community really talking about hospital in the home. That’s another big theme I’ve heard here this week and where you’re seeing reimbursement kind of drive where they’re going to put technology. So hospitals are funding that infrastructure in terms of iPads, ethernet, those types of things to where patients can get better where they probably are the most comfortable which is right on their couch at home.

I’ve seen lots of discussions about prior authorization, some of the rules that are out there, that’s probably the bane of existence of most of the parties here, both on the payer and provider side. I think there’s huge opportunities for FinThrive in this space as we operate a lot in those data sets, are responsible for brokering a lot of those transactions between patient, provider, and payer, and looking really forward to taking a lot of these insights and applying them through our technologies as we move forward.”

Article written by Nakita Rowell-Stevens.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512